vTv Therapeutics (VTVT) Accumulated Depreciation (2014 - 2021)

vTv Therapeutics has disclosed Accumulated Depreciation across 8 years of filings, most recently posting $305000.0 for Q4 2021.

• In Q4 2021, Accumulated Depreciation rose 41.2% year-over-year to $305000.0; the TTM figure through Dec 2021 stood at $305000.0 (up 41.2% YoY), while the FY2021 annual figure was $305000.0, up 41.2% from the prior year.
• Accumulated Depreciation came in at $305000.0 for Q4 2021 at vTv Therapeutics, up from $216000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $9.1 million in Q4 2017 to a low of $148000.0 in Q4 2019.
• Average Accumulated Depreciation over 5 years is $3.6 million, with a median of $305000.0 recorded in 2021.
• Year-over-year, Accumulated Depreciation slumped 98.24% in 2019 and soared 45.95% in 2020.
• Over 5 years, Accumulated Depreciation stood at $9.1 million in 2017, then decreased by 7.51% to $8.4 million in 2018, then tumbled by 98.24% to $148000.0 in 2019, then jumped by 45.95% to $216000.0 in 2020, then jumped by 41.2% to $305000.0 in 2021.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $305000.0 in Q4 2021, $216000.0 in Q4 2020, and $148000.0 in Q4 2019.